MILPITAS, Calif. — Deoxyribonuclease I (DNAse I) is an endonuclease that cleaves DNA phosphodiester bonds. DNAse I targets single-stranded DNA, double-stranded DNA, and chromatin in a non-specific manner. Abnormal DNAse I activity occurs in association with a variety of cancers and auto-immune diseases that exhibit elevated levels of cell-free DNA. BioVision’s DNAse I Activity Fluorometric Assay […]
Agreement enables Oxford Genetics to expand its existing product and service portfolio and further support bio-therapeutic discovery and development Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies, signs a worldwide distribution agreement with CLS Cell Lines Service GmbH (CLS) to enhance its range of biotherapeutic research products and service. The […]
Unique cell analysis platform for basic research and drug discovery has broad and expanding user base Acquisition to significantly enhance Sartorius’ Bioanalytics portfolio Goettingen – Sartorius, a leading partner to the biopharmaceutical industry and laboratories, today signed an agreement to acquire U.S. based Essen BioScience Inc., a pioneer and leader in the field of cell-based […]
PierianDx announced today that six leading healthcare systems and academic medical centers have chosen its leading “One Space” genomics software solution, CGW, to streamline clinical lab workflow, analysis, interpretation and reporting. More than 40 members of the PierianDx Partner Sharing Network utilize the shared constitutional and somatic genomic data within CGW to target patient-specific diagnosis […]
GenetiSure Dx Postnatal Assay Can Help Move Inquiries from Cause to Care Faster SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) has introduced its first comparative genomic hybridization (CGH) assay for diagnostic use: the GenetiSure Dx Postnatal Assay. This assay will enable clinical geneticists to detect genetic anomalies earlier and more accurately than traditional methods […]
– David Roth appointed Chief Financial Officer (CFO) – Pilar de la Huerta continues to serve as Co-CEO and is appointed Chief Business Development Officer (CBDO) – SYGNIS realigns its management to further accelerate growth Madrid, Spain, and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that the Supervisory Board […]
Camarillo, CA –Hygiena, a Warburg Pincus portfolio company that specializes in rapid food safety and environmental sanitation testing, today announced the successful completion of its acquisition of DuPont Diagnostics, the global food safety diagnostics business of DuPont. The business was originally formed in 1992 as Qualicon. Hygiena will now sell the former DuPont Diagnostics products […]
Austria – Today Lexogen, a transcriptomics and next generation sequencing company, announces the start of its RNA-Seq service, which focuses on gene expression profiling using Lexogen’s proprietary QuantSeq technology. Lexogen’s QuantSeq 3’ mRNA-Seq Library Prep Kit has already been recognized as one of the fastest, most cost-efficient, and accurate methods for expression profiling using next […]
Financing led by ARCH Venture Partners with the largest investment by Johnson & Johnson Innovation; includes additional strategic industry and venture investors GRAIL plans a second close with institutional investors to bring the total raised in the Series B to over $1 billion MENLO PARK, Calif. — GRAIL, Inc., a life sciences company whose mission […]
Mountain View, CA—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of WaferGen Bio-systems, Inc. (“WaferGen”), WaferGen has become a wholly-owned subsidiary of TBUSH as of February 28, 2017 (US local time). Under the merger agreement executed with WaferGen, TBUSH paid 35.9 million US dollars to acquire 100% of the equity […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
